Polaris Diagnostics LLC

As one of the leading brands in us Diagnostic market of Thrombosis and Hemostasis, POLARIS was founded in 2015. The headquarter is based in US International Medical Zone, with a R&D and manufacturing center of about 7,000 square meters. The products are widely sold all over USA. POLARIS has been focusing on the research and development of POCT molecular diagnostic products combining high technology and biotechnology. Based on POCT molecular diagnosis technologies, Igenesis has successfully developed a series of multiple nucleic acid detection products, which can be applied to the fields of microbial detection, genetic detection for personalized medicine, cancer detection, forensic evidence, food safety, etc.

Under the new trend of "Sample in, Results Out" of global molecular diagnosis, POLARIS has become one of the leading providers of automated fully enclosed qPCR systems with strong technical advantages and market competitive ability. POLARIS ' innovative POCT molecular diagnostic system provides highly integrated and fully enclosed solutions for qPCR detection. It is widely used in medical institutions, CDCs, forensic centers, etc.